Carmell Therapeutics Corporation Cash Flow Quality Index
Carmell Therapeutics Corporation cash flow quality index. Carmell Therapeutics Corporation (CTCX) has a Cash Flow Quality Index of -0.07x as of December 2024. Operating cash flow of $-772.06K is below net income of $10.84 Million, suggesting accrual-heavy earnings not yet converted to cash. See Carmell Therapeutics Corporation (CTCX) flexibility index to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Carmell Therapeutics Corporation Cash Flow Quality Index by Year (None–None)
Carmell Therapeutics Corporation cash flow quality index by year from None to None. Year-by-year earnings quality comparison for Carmell Therapeutics Corporation. For the full cash flow conversion analysis, see cash flow conversion of Carmell Therapeutics Corporation.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|